Variant report

Variant	esv3525599
Chromosome Location	chr1:171408816-171412079
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr1:171404013..171405651-chr1:171411065..171412627,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-MYOC-4	chr1:171410062-171410336	NONHSAT007529
2	lnc-MYOC-4	chr1:171410851-171411265	NONHSAT007529

Extended variants
information (count: 146 )
Associated
traits (count: 92 )

Variant overlapped rSNPs/rCNVs (count:146 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs534675407	chr1:171408830-171408831	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs553422433	chr1:171408833-171408834	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs575039735	chr1:171408876-171408877	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs183518981	chr1:171408919-171408920	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs559761151	chr1:171408933-171408934	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs201527874	chr1:171408934-171408935	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs79800910	chr1:171408935-171408936	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs397981940	chr1:171408948-171408949	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs371239846	chr1:171408998-171408999	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs11804544	chr1:171409004-171409005	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs11804545	chr1:171409006-171409007	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs188547421	chr1:171409045-171409046	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs80197619	chr1:171409046-171409047	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs545970548	chr1:171409055-171409056	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs11583893	chr1:171409061-171409062	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs181056013	chr1:171409146-171409147	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs547265158	chr1:171409150-171409151	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs143774376	chr1:171409160-171409161	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs530929226	chr1:171409162-171409163	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs552468212	chr1:171409181-171409182	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs11804581	chr1:171409187-171409188	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs550510618	chr1:171409333-171409334	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs36082756	chr1:171409365-171409366	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs113630306	chr1:171409405-171409406	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs376300926	chr1:171409426-171409427	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs186937954	chr1:171409433-171409434	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs57508011	chr1:171409437-171409438	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs375639233	chr1:171409447-171409448	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs114693736	chr1:171409494-171409495	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs386636757	chr1:171409513-171409514	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs7549726	chr1:171409515-171409516	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs568672264	chr1:171409519-171409520	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs536188225	chr1:171409524-171409525	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs557368757	chr1:171409577-171409578	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs575940693	chr1:171409581-171409582	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs546405047	chr1:171409588-171409589	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs557904058	chr1:171409592-171409593	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs191824214	chr1:171409602-171409603	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs572947801	chr1:171409610-171409611	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs182223991	chr1:171409663-171409664	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs187470889	chr1:171409697-171409698	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs528871279	chr1:171409741-171409742	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs151056827	chr1:171409795-171409796	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs562617388	chr1:171409796-171409797	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs61816632	chr1:171409806-171409807	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs373817425	chr1:171409809-171409810	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs141007615	chr1:171409810-171409811	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs570631098	chr1:171409834-171409835	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs368756843	chr1:171409839-171409840	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs564704515	chr1:171409840-171409841	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:92)

Disease	PMID	Source
Breast cancer	17603634	CNVD
Esophageal squamous carcinoma	21637470	CNVD
HIV/AIDS	22032296	CNVD
Schizophrenia	19415332	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	16750200	CNVD
Liposarcoma	21253554	CNVD
Burkitt''s lymphoma	18698080	CNVD
Melanoma	18172304	CNVD
Cancer	21183584	CNVD
Multiple myeloma	16461302	CNVD
Rett syndrome	21593744	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Medulloblastoma	21979893	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	17133270	CNVD
Non-small cell lung cancer	21829676	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Non-small cell lung cancer	21044232	CNVD
Cervical cancer	21063398	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	20632083	CNVD
Endometrial cancer	22040021	CNVD
Ewing''s sarcoma	21437220	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	21264507	CNVD
Multiple myeloma	21628407	CNVD
Cancer	16751803	CNVD
Prostate cancer	16705090	CNVD
Neuroblastoma	19435921	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16461572	CNVD
Intracranial tumor	16823260	CNVD
Medulloblastoma	18056178	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Neuroblastoma	21899760	CNVD
Bladder cancer	19088036	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17002787	CNVD
Breast cancer	21858162	CNVD
Retinoblastoma	19183342	CNVD
Non-small cell lung cancer	21385341	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	16608533	CNVD
Ewing''s sarcoma	22429812	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Chordoma	18071362	CNVD
Hepatocellular carcinoma	18803288	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	17001317	CNVD
Urothelial carcinoma	21177765	CNVD
Burkitt''s lymphoma	19759907	CNVD
Acute myeloid leukemia	21251322	CNVD
Multiple myeloma	17550852	CNVD
Prostate cancer	18632612	CNVD
Acute myeloid leukemia	20729466	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Testicular germ cell tumor	18059402	CNVD
Trisomy 5 syndrome	21098271	CNVD
Ependymoma	18628472	CNVD
Leukemia	18628472	CNVD
Breast cancer	21611746	CNVD
Neuroblastoma	18923191	CNVD
Soft tissue tumor	16732325	CNVD
Cancer	17060936	CNVD
Lung cancer	16740712	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Ewing''s sarcoma	17952124	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Acute lymphoblastic leukemia	19100363	CNVD
Williams-beuren syndrome	16971481	CNVD
Developmental delay	21147756	CNVD
Burkitt''s lymphoma	20823134	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Breast cancer	20409316	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Pancreatic cancer	17952125	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	21509527	CNVD

Chromatin state (count:30 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr1:171404800-171410600	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
2	chr1:171407000-171411000	Enhancers	NHEK	skin
3	chr1:171407200-171409200	Enhancers	Hela-S3	cervix
4	chr1:171407200-171411000	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
5	chr1:171407400-171409000	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
6	chr1:171407400-171411200	Enhancers	NHDF-Ad	bronchial
7	chr1:171407800-171409200	Enhancers	NHLF	lung
8	chr1:171408200-171409000	Enhancers	Foreskin Fibroblast Primary Cells skin02	Skin
9	chr1:171408400-171410200	Weak transcription	HUVEC	blood vessel
10	chr1:171408400-171410400	Weak transcription	Muscle Satellite Cultured Cells	--
11	chr1:171408400-171410600	Weak transcription	NH-A	brain
12	chr1:171408400-171410800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
13	chr1:171408600-171410400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
14	chr1:171408600-171410600	Weak transcription	Osteobl	bone
15	chr1:171408800-171410600	Weak transcription	HMEC	breast
16	chr1:171409000-171415200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
17	chr1:171409200-171410200	Weak transcription	Hela-S3	cervix
18	chr1:171410200-171410400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
19	chr1:171410200-171410800	Enhancers	HUVEC	blood vessel
20	chr1:171410200-171411200	Enhancers	Hela-S3	cervix
21	chr1:171410400-171411200	Enhancers	Muscle Satellite Cultured Cells	--
22	chr1:171410400-171411200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
23	chr1:171410600-171410800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
24	chr1:171410600-171410800	Enhancers	NH-A	brain
25	chr1:171410600-171411000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
26	chr1:171410600-171411200	Enhancers	HMEC	breast
27	chr1:171410600-171411200	Enhancers	Osteobl	bone
28	chr1:171410800-171411000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
29	chr1:171411200-171413800	Weak transcription	NHDF-Ad	bronchial
30	chr1:171411200-171415000	Weak transcription	Osteobl	bone

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links